research-focus Research Focus International Scientific Journal Research Focus 2181-3833 Ilm-fan va innovatsiyalar akademiyasi 10.66073/researchfocus.v2i5.247 REL-A-010612 ASSESSMENT OF THE EFFECTIVENESS OF THE CLINICAL AND PHARMACOECONOMIC ASPECTS OF TOPAMAX IN PATIENTS WITH EPILEPSY ОЦЕНКА ЭФФЕКТИВНОСТИ КЛИНИЧЕСКИХ И ФАРМАКОЭКОНОМИЧЕСКИХ АСПЕКТОВ ПРЕПАРАТА ТОПАМАКС У БОЛЬНЫХ ЭПИЛЕПСИЕЙ EPILEPSIYA BILAN OG‘RIGAN BEMORLARDA TOPAMAX DORI VOSITASINING KLINIK VA FARMAKOEKONOMIK ASPEKTLARINING SAMARADORLIGINI BAHOLASH Arslonova Rayxon Rajabboevna Assistant of the Department of Pharmacology, Samarkand State Medical University Narmetova Sevara Yangiboyevna Assistant of the Department of Pharmacology, Samarkand State Medical University 05 06 2023 2023 2 5 198 202 https://creativecommons.org/licenses/by/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.

This scientific article concerns epilepsy, a disease widespread in medicine, which is one of the common diseases of the nervous system requiring long-term treatment. According to the statistical data of the European Commission on epilepsy, about 50 million people in the world suffer from epilepsy. The development of epilepsy is caused by hereditary and genetic factors and, following traumas and infectious diseases, by perinatal damage to the brain. At present, the number of patients with epilepsy in European countries is increasing.

Данная научная статья посвящена эпилепсии — широко распространённому в медицине заболеванию, которое является одним из распространённых заболеваний нервной системы, требующих длительного лечения. По статистическим данным Европейской комиссии по эпилепсии, в мире эпилепсией страдают около 50 миллионов человек. Развитию эпилепсии способствуют наследственные, генетические факторы, а также перенесённые травмы, инфекционные заболевания и перинатальное поражение головного мозга. В настоящее время число больных эпилепсией в европейских странах возрастает.

Mazkur ilmiy maqola tibbiyotda keng tarqalgan epilepsiya kasalligi haqida bo‘lib, bu -  kasallik uzoq muddatlar daomida davolash zarur bo‘lgan nerv tizimining keng tarqalgan kasalliklardan biri hisoblanadi. Epilepsiya kasalligi bo‘yicha butun Evropa komissiyasining statistik ma‘lumotlariga qaraganda, dunyoda 50 millionga yaqin odamlarda epilepsiya uchraydi. Epilepsiya kasalliklarining rivojlanishida nasliy, irsiy omillar va travmalardan so‘ng, infektsion kasalliklardan so‘ng,  miyaning perinatal shikastlanishi sabab bo‘ladi. Hozirgi davrda epilepsiya bilan og‘rigan bemorlar Evropa mamlakatlarda ortib bormoqda.

 Epilepsiya topamax dori vositasi kasallik,tutqanoq xurujlari Эпилепсия препарат топамакс заболевание, эпилептические приступы Epilepsiya topamax dori vositasi kasallik, tutqanoq xurujlari Bakuns G.O., Burd G.S., Vayntrub M.Ya. i dr. Jur. Nevrologii i psixiatrii, 1995 g., t. 95, № 3, str. 41-44 Voronova T.A. - «Antikonvulsanti v psixiatricheskoy i nevrologicheskoy praktiki». Pod red. A.M.Veyna i S.N.Mosolova, S-P6, 1994, str. 3-30. Volf P. - Jur. Nevropatologii i psixiatrii, 1993 g., № 1, str. 36- 38. Eli M.J., trayrer Dj.X. Protivosudorojnaya terapiya. M., 1983 g V.V.Kalinin, Ye.V.Jeleznova i dr. - Monoterapiya parsialnix form epilepsii topamaksom. Jur. Nevrologii i psixiatrii, 7, 2018 g. S.A.Gromov, R.A.Xarionova dr. - Topamaks v sisteme medikamentoznogo lecheniya epilepsii. 3. 2020 g. K.Yu.Muxin, L.Yu.Gluxova Topamaks pri monoterapii epilepsii. Jur. Nevrologii i psixiatrii. 8. 2018 g. Rajabboevna A. R. et al. THE IMPORTANCE OF COMPLEX TREATMENT IN HAIR LOSS //Web of Scientist: International Scientific Research Journal. – 2022. – Т. 3. – №. 5. – С. 1814-1818. Aslam I. et al. Novel oral anticoagulants for treatment of deep venous thrombosis and pulmonary embolism //Eurasian Research Bulletin. – 2021. – Т. 1. – №. 1. – С. 59-72. Jiyanboevich Y. S., Rajabboevna A. R., Salimovna N. Z. Study Of Anti-Inflammatory Properties Of Paranitrophenylgyoxilic Acid Thyosemicarbase //European Journal of Molecular & Clinical Medicine. – 2020. – Т. 7. – №. 3. – С. 2711-2715. Rajabboevna A. R., Farmanovna I. E., Ergashboevna A. Z. YOD TANQISLIGI FONIDA BOLALARDA SHAKLLANISH VA RIVOJLANISH BUZILISHLARNING O’ZIGA XOS XUSUSIYATLARI //BARQARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI. – 2022. – С. 350-352. Jiyanboyevich Y. S., Aslam I., Rajabboevna A. R. The Comparison Between Management Versus Percutaneous Coronary Intervention (PCI) Patients With Coronary Artery Disease (CAD) //The American Journal of Medical Sciences and Pharmaceutical Research. – 2021. – Т. 3. – №. 06. – С. 189-194. 10.37547/tajmspr/volume03issue06-29 Rajabboevna A. R., Suyunovich B. E. The Significant Significance of the Medicinal Plant in Zizyphus in Lowering Blood Pressure //Scholastic: Journal of Natural and Medical Education. – 2023. – Т. 2. – №. 4. – С. 169-171. Baxodirovna S. D., Rajabboevna A. R. GIPERTONIYA KASALLIGIDA KALTSIY KANALLARI ANTAGONISTLARINI QO'LLANILISHI //BARQARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI. – 2022. – С. 485-488. Atabaevich S. M., Rajabboevna M. D. REFLECTION OF THE RESEARCHERS WORKS ABOUT THE FIRST URBAN DEVELOPMENT AND STATEHOOD PROBLEMS IN THE LOWER AMUDARYA REGION //EPRA International Journal of Socio-Economic and Environmental Outlook (SEEO). – 2022. – Т. 9. – №. 12. – С. 38-44.